跳至主要内容
临床试验/ACTRN12620000131954
ACTRN12620000131954尚未招募未知

Double blind randomised, placebo-controlled clinical trial of transcutaneous electric stimulation in the treatment of chronic constipation in children

Waikato DHB0 个研究点目标入组 108 人开始时间: 2020年2月11日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
5 Years 至 15 Years(—)
性别
All

入选标准

  • Children between age 5 and 15 referred to Waikato DHB(New Zealand) Paediatric Outpatient Service with Constipation
  • Primary diagnosis of chronic idiopathic constipation (Functional Constipation) by clinician

排除标准

  • Patients with an identified organic cause for constipation - namely:
  • Cystic Fibrosis
  • Hirschsprung's disease
  • Spinal Malformations
  • Known anorectal malformations
  • Previous surgery for constipation including appendicostomy but not including manual evacuation
  • Patients with a recent admission for nasogastric washout of constipation within the last 6 weeks
  • Children where cosnsent can't be reasonably obtained

研究者

发起方
Waikato DHB

相似试验

进行中(未招募)
不适用
Double blind, placebo-controlled randomized clinical trial to evaluate the efficacy and safety of a transtympanic treatment of tinnitus with caroverine - Caroverin and inner ear diseasesCaroverine infusions have been used successfully in Austria to treat cochlear-synaptic tinnitus. This treatment is very time consuming and needs a constant monitoring of the physician.This study will investigate the efficacy and safety of caroverine eardrops for transtympanic treatment of tinnitus.The aim is to ascertain whether the results of the proof of concept study using a 1,5 % solution can be reproduced.
EUCTR2009-018046-38-ATPhafag AG
进行中(未招募)
1 期
A clinical trial to demonstrate the safety and efficacy of a healing water (Gerolsteiner Heilwasser) on heartburn compared to placebofunctional dyspeptic complaints, particularly heartburn (at least 3 months prior to study start, on at least 4 days per week)MedDRA version: 19.0 Level: LLT Classification code 10019326 Term: Heartburn System Organ Class: 100000004856
EUCTR2016-000994-19-DEGerolsteiner Brunnen GmbH & Co. KG80
已完成
2 期
A clinical trial to study the effect of Arjuna in heart failure patients
CTRI/2010/091/000415Department of Biotechnology Government of India100
招募中
不适用
Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya Granules in treating patients with essential hypertension of kidney deficiency type
ITMCTR1900002876Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
进行中(未招募)
不适用
Doubleblind, randomized, placebo controlled clinical trial to proof the efficacy of a comfrey extract in subjects with painfull gonarthrosis
EUCTR2005-003144-65-DEMerck Selbstmedikation GmbH220